Conference posters 2023

Winner 2023

'Natalizumab - Real World Data - Switching from IV infusions to Subcutaneous injection. Patient experience' by Vanessa Cardoso and Liliana Plesca was the 2023 winning poster.

Highly commended posters

BeeWellwithMS: The science and wellbeing podcast for people with MS (PDF, 670KB)
Straukiene, A., and Hughes, S.

MS and Exercise: what are patients thinking? Exploring attitudes to physical activity in 2023 (PDF, 225KB)
Douglas, L., and Kharin, A.

A-Z of posters

(FES) Service Increasing student capacity using a different model of clinical education: The benefits and challenges (PDF, 250KB)
Peace, C., and Aldridge, D.

A Geographical Review of Multiple Sclerosis (MS) Patients who Access the Birmingham Functional Electrical Stimulation (FES) Service (PDF, 485KB)
Grabarz, R.

Can a Master's degree in advanced clinical practice clarify the UK multiple sclerosis nurse specialist as an advanced practice role (PDF, 210KB)
Webster, J.

Case Study: Multi-faceted, long-term use of Functional Electrical Stimulation (FES) (PDF, 530KB)
Maycock, L., and Mardon, N.

Diroximel Fumarate in Young Adults With Relapsing-Remitting Multiple Sclerosis: Interim Safety and Efficacy Results From the Phase 3 EVOLVE-MS-1 Study (PDF, 215KB)
Wray, S., Zhu, C., Singer, B.A., et al.

Disease-Modifying Therapy Choice in People With Multiple Sclerosis in the Era of Covid-19: Characterizing Outcomes in Patients Who Switched From Anti-CD20 Therapies to Diroximel Fumarate (PDF, 190KB)
Kaczmarek, O., Sethi, A., Teng, E., et al.

Do people with multiple sclerosis (MS) and health professionals share perceptions on exercise delivery and support? (PDF, 125KB)
Hensman, M.Y., Veldhuijzen van Zanten, J.J.C.S., Douglas, M. et al.

Efficacy and Safety in Phase 3 EVOLVE-MS-1 After Switching from Glatiramer Acetate or Interferon or Continuing on Diroximel Fumarate (PDF, 219KB)
Wray, S., Bergh, F., Wundes, A., et al.

Family planning and pregnancy in Multiple Sclerosis: have we changed pregnancy outcomes with proactive use of Disease Modifying Treatments? (PDF, 310KB)
Lyons, L.

Flushing and Gastrointestinal Adverse Event Analysis From the Phase 3 EVOLVE-MS-1 Study of Diroximel Fumarate in Patients With Relapsing-Remitting Multiple Sclerosis (PDF, 210KB)
Faissner, S., Antezana, A.O., Hernández Pérez, M.A., et al.

Is there anything you would like to tell us about your experience today? A Content Analysis (PDF, 215KB)
Swain, P., Taylor, L., Morris, H. et al.

Joined up thinking, setting up a Multiple Sclerosis / Urology Service (PDF, 330KB)
Rice, L., and Reid.

MS cognition clinic handbook - Karger Fast Facts: Cognition in Multiple Sclerosis (PDF, 465KB)
Langdon, D., and Young, C.

Peer Connect: A Feasibility RCT of Peer Coaching for Adults with Long-term Conditions (PDF, 290KB)
Dennett, R., Straukiene, A., Thompson, T. et al.

Real own experience of Kesimpta (Ofatumumab) across the Thames Valley Hospitals (PDF, 295KB)
Wyatt, S.

Recognising Quality in the Delivery of Services in Multiple Sclerosis (PDF, 430KB)

Refuel-MS: Developing, optimising, and implementing a blended digital self-management treatment for fatigue in multiple sclerosis (PDF, 400KB)
Moss-Morris, R., Freeman, J., Hendrie, W., et al.

Safety and Clinical Efficacy Outcomes from the Long-Term Extension Study of Tolebrutinib in Patients with Relapsing Multiple Sclerosis: 2-Year Results (PDF, 70KB)
Oh, J., Syed, S. , Orogun, L., et al.

Tackling domestic violence and abuse: What is the role of the healthcare professional working with people with multiple sclerosis? (PDF, 3.51MB)
Britt, S.

Using the Guys Neurological Disability Scale as a Tool to Evaluate Multiple Sclerosis (MS) Symptom Severity and Prevalence in Patients Attending the MS Specialist Rehabilitation Clinic (PDF, 195KB)
Fisher, R.